Matters needing attention in etimicin sulfate injection

1. During the treatment with this product, the changes of renal function and the function of the eighth cranial nerve should be closely observed, and the blood drug concentration should be detected as much as possible, especially for patients with renal insufficiency or failure, patients with extensive burns, newborns, premature infants, infants and the elderly, patients with shock, heart failure, ascites, patients with severe dehydration and patients with large fluctuations in renal function in a short period of time. 2. This product belongs to aminoglycoside antibiotics, which may cause neuromuscular block. Therefore, special attention should be paid to patients with hematological diseases who receive anesthetics, succinylcholine, Tobalin or a large amount of citric acid anticoagulation. Once neuromuscular block occurs, this product should be stopped and treated with intravenous calcium salt. 3. During the use of this product, if there are any adverse events and/or adverse reactions, please consult a doctor. 4. During the use of this product, if there are any adverse events and/or adverse reactions, please consult a doctor. Please keep it out of the reach of children.